Where will leukemia research go next?
Key therapeutic advances in follicular lymphoma
The mechanisms driving relapse in multiple myeloma
The impact of the clinical trial of venetoclax (ABT-199) and obinutuzumab in CLL
The importance of targeting proliferating and quiescent cells in CLL